MyFinsight
Home
Blog
About
Net proceeds from
sale of future...
$60,000K
(-13.88%↓ Y/Y)
Proceeds from stock
option exercises and...
$173K
(162.12%↑ Y/Y)
Proceeds from maturities
of marketable...
$61,900K
(129.80%↑ Y/Y)
Net cash provided by
financing activities
$60,173K
(-13.37%↓ Y/Y)
Net cash provided by
(used in) investing...
$27,965K
(200.83%↑ Y/Y)
Canceled cashflow
$33,935K
Net change in cash
and cash...
$47,390K
(190.87%↑ Y/Y)
Canceled cashflow
$40,748K
Non-cash loss on
extinguishment of royalty...
-$52,762K
Net loss
$19,515K
(125.25%↑ Y/Y)
Accrued expenses and
other current...
$11,098K
(245.05%↑ Y/Y)
Non-cash interest
expense
$4,016K
(584.16%↑ Y/Y)
Share-based compensation
expense
$1,974K
(-75.56%↓ Y/Y)
Prepaid expenses and
other current assets
-$809K
(83.36%↑ Y/Y)
Accounts payable
$794K
(304.64%↑ Y/Y)
Depreciation and
amortization
$708K
(-80.75%↓ Y/Y)
Loss on disposal of
assets
-$353K
Inventory
-$347K
(-103.74%↓ Y/Y)
Non-cash lease expense
$292K
(-63.45%↓ Y/Y)
Purchases of marketable
securities
$33,129K
(-37.99%↓ Y/Y)
Purchases of property,
equipment and software
$806K
(-35.21%↓ Y/Y)
Net cash used in
operating activities
-$40,748K
(56.59%↑ Y/Y)
Canceled cashflow
$92,668K
Gain on sale of cdmo
operations before...
$94,842K
Accounts receivable
$25,949K
(215.57%↑ Y/Y)
Non-cash royalty revenue
$7,344K
Deferred revenue
-$4,299K
(47.61%↑ Y/Y)
Amortization of premiums and
discounts on marketable...
$445K
(-9.74%↓ Y/Y)
Other non current
liabilities
-$276K
(8.00%↑ Y/Y)
Lease liabilities
-$261K
(-21.96%↓ Y/Y)
Back
Back
Cash Flow
MACROGENICS INC (MGNX)
MACROGENICS INC (MGNX)
source: myfinsight.com